spacer
home > ict > Spring 2016
PUBLICATIONS

International Clinical Trials

ict
Spring 2016

   
Text
PDF
Editor's Comment

Graham Hughes
introduces this issue by outlining the two sides of clinical trial data – transparency on the one hand, and protection on the other hand – among other topics.

 
view
download pdf
bullet
Clinical Trial Management
Site Activation

Head Start


First and foremost, each clinical trial needs to undergo site activation – which can be a lengthy and tiresome process, says Melissa Easy at DrugDev. There are, however, three models at hand using the most recent technology to help facilitate trial start-up.

 
view
download pdf
Paediatric Trials

On Your Doorstep


With paediatric trials becoming more common, Dr Graham Wylie at MRN states that home visits in particular are part of an increasingly patient-centric healthcare movement.


 
view
download pdf
bullet
MARKETPLACE
End Point

Activity Surge

Graham Hughes
reports on the increasing activity in M&A over the past few decades, and outlines reasons for merging and the implications for consumers and stakeholders.

 
view
download pdf
Marketing Applications

The Final Step


Representing the last hurdle in bringing a drug to market, marketing applications can be costly and time consuming to develop. Rho’s David Shoemaker presents different application models to facilitate this procedure.


 
view
download pdf
bullet
Regional trials
Regional Trials

Across the Globe


ICT takes a closer look at the clinical trial landscape in different markets – namely Latin America, the MENA region, Indonesia and finally, in the EU.

 
view
download pdf
Latin America

Susana Bule and Cláudia Carvalho at Eurotrials reveal that the Latin American market has been demonstrating great potential for clinical research and pharmaceutical development for some years now. The spending in healthcare has also been increasing, which shows the governments’ prioritisation of this matter.


 
view
download pdf
The Middle East and North Africa

Cellia Habita at ARIANNE explores clinical trials in the Middle East and North Africa, and explains why these areas should not be neglected in favour of more familiar countries.

 
view
download pdf
Indonesia

Rutger Oudejans at UBM EMEA highlights the importance of local expertise in Indonesian clinical trials, and describes why this region has gained significant value in pharma as a whole.

 
view
download pdf
European Union

Srikanth Venkataraman
at Frost & Sullivan explores patient recruitment for global clinical trials – with a focus on the EU – which he believes are going to be transformed by digital platforms and mobile technologies.

 
view
download pdf
bullet
data management & statistical analysis
Data Protection

Under Wraps

8MAN’s Jens Puhle
believes that keeping data safe from rival organisations and potential theft is paramount in pharma – with threats being closer to home than one might think.

 
view
download pdf
Clinical Trial Data

Access Denied

Graham Donaldson
at TRAC Services looks at the transparency of data versus the protection of commercially confident information in light of the latest regulations introduced to Europe.

 
view
download pdf
Data Analytics

The More, The Merrier


There is no doubt that data plays an important role in pharma – and with a growing focus on the patient in the form of personalised medicine and services, this role is set to further expand, states Wipro Ltd’s Nitin Raizada.

 
view
download pdf
Data Formatting

Preparing for SEND

Roman Radelicki
at SGS believes that implementing the standardised electronic format SEND can help streamline the process of submitting electronic data in non-clinical studies, and can further save time and money.

 
view
download pdf
bullet
Drug delivery & Therapeutics
Rare Disease Treatment

Making a Difference

World Courier’s Sue Lee
discusses the growing importance of orphan drugs, which must be produced in small quantities for a limited patient population, and questions the fact that only 5% of rare diseases have treatments available.

 
view
download pdf
bullet
Supply Chain & Manufacturing
Clinical Supply Chains

On Demand


Adaptive trial design is becoming increasingly popular, observes Catalent’s Dr Paul Ingram, before investigating its implications on supply chain efficiency.

 
view
download pdf
Logistics and Handling

Touch Point

Essangui Mbaitjongue
at Thermo King is convinced that with the help of tighter temperature guidelines, the shipment of pharmaceuticals can be facilitated – thus enabling them to reach their destination unharmed.

 
view
download pdf
bullet
Central Labs
Microbiological Labs

Driven by Results: Part 2


Olga Sazonova, Veronika Khokhlova, Maxim Belotserkovsky
and Andrey Karelin at PSI CRO continue examining quantitative urine culture studies, and consider country-specific differences.

 
view
download pdf

Cancer Therapeutics
Pharmacogenomics and Oncology

Special Treatment

United BioSource Corporation’s Dr Don Gabriel
outlines the implications of the use of pharmacogenomics – the study of individuals’ genetic variations – on oncology, and how that impacts the way patients respond to medication.


 
view
download pdf
Oncology Research

Relationships Matter

Dr Martin Lachs
at ICON examines the connection between sites and CROs when enrolling patients in oncology studies, and considers how to further improve this relationship.

 
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

Lynparza recommended for approval in EU by CHMP for BRCA-mutated metastatic pancreatic cancer

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that Lynparza (olaparib) has been recommended for marketing authorisation in the European Union (EU) for the 1st-line maintenance treatment of patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the Phase III POLO trial, which were published in The New England Journal of Medicine.
More info >>

White Papers

e-tools enhance clinical trial performance

e-novex

In today’s ever-evolving medical business, technological changes require innovation to meet growing market demands and to bring about advances in the industry. One such development currently taking place in the field of clinical research is how e-tools are initiating a boost in the productivity of clinical trials.
More info >>

Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement